Hodge, Jennifer A <br/><br/>
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.  [electronic resource] 

 -  Clinical and experimental rheumatology   
 - 318-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0392-856X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arthritis, Rheumatoid--drug therapy<br/>Cytokines--physiology<br/>Humans<br/>Janus Kinases--antagonists & inhibitors<br/>Lymphocyte Subsets--drug effects<br/>Neutrophils--drug effects<br/>Piperidines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>Signal Transduction--physiology